5.770
5.77 (0%)
As of Dec 24, 2024
Verve Therapeutics, Inc. [VERV]
Source:
Company Overview
Verve Therapeutics, Inc.is a clinical-stage genetic medicines company pioneering a new approach to the care of cardiovascular disease, or CVD, transforming treatment from chronic management to single-course gene editing medicines.
| Country | United States |
| Headquarters | boston, massachusetts |
| Phone Number | (978) 501-3026 |
| Industry | |
| CEO | Sekar Kathiresan |
| Website | http://www.vervetx.com |